Century Therapeutics has announced that it has acquired Empirica Therapeutics, allowing the company to develop its iPSC derived allogeneic cell therapies against glioblastoma (GBM).
Bausch Health Companies has announced that Health Canada has approved the use of DUOBRII™ lotion, a topical prescription medicine used to improve the signs and symptoms of plaque psoriasis in adult patients with moderate to severe plaque psoriasis.
The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) have announced details of the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.
MyndTec has partnered with Maness Veteran Medical to distribute its MyndMove™ Device to the US Department of Defense and The Department of Veterans Affairs.
Epineuron Technologies, Inc., announces the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.
Lumira Ventures has launched the Double Bottom Line Challenge to provide funding to community organizations which are supporting groups that have been significantly affected by COVID-19.
The Velocity Fund Pitch Competition is open for applications. The Fund will invest $50,000 to $100,000 in each of the top four promising, early-stage companies.
Microbix Biosystems has attained medical devices establishment licensing from Health Canada, allowing the immediate use of its quality assessment products by clinical laboratories across the country,
Microbix Biosystems Inc. and Oneworld Accuracy have announced a collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing.
Mobio Health has announced that it has teamed up with the New York University School of Medicine and the Zurich Psychiatry Hospital to deliver free digital stress-resilience training.
Self Care Catalysts has launched a collaboration with Roche through the Roche COVID-19 Data Science Coalition project. The initiative will use Self Care Catalysts’ Health Storylines as the offiicial COVID-19 app that will collect data from the community.